JUBILANT PHARMOVA LTD
Latest filings
- Newspaper notice on physical share transfers and shareholder details · Compliance
- Newspaper ads published for Postal Ballot notice · Compliance
- Postal Ballot: Approval for NCD Issuance up to Rs 2,500 crore · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹8,608 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from JUBILANT PHARMOVA LTD's filed financials and exchange disclosures
What does JUBILANT PHARMOVA LTD do?
JUBILANT PHARMOVA LTD is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol JUBLPHARMA.
Is JUBILANT PHARMOVA LTD profitable?
Yes. Over the trailing twelve months JUBILANT PHARMOVA LTD reported a net profit of ₹351 Cr on revenue of ₹8,608 Cr.
Does JUBILANT PHARMOVA LTD pay a dividend?
Yes. The dividend yield is 0.52% at the current price. It paid out 20% of its profit as dividend in FY26.
Is JUBILANT PHARMOVA LTD debt-free?
No. It reported borrowings of ₹3,220 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹1,952 Cr after cash. Debt stands at 0.45× equity. That is higher than 79% of its 166 Pharmaceuticals peers.
Is JUBILANT PHARMOVA LTD expensive compared with its peers?
On trailing P/E, JUBILANT PHARMOVA LTD ranks 110 of 158 in Pharmaceuticals — cheaper than 31% of them, against an industry median of 30.1×. This is a position, not a valuation judgement.
How much does the JUBILANT PHARMOVA LTD share price move in a day?
On a typical session JUBILANT PHARMOVA LTD moves 1.10% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track JUBILANT PHARMOVA LTD's announcements?
Every NSE and BSE filing by JUBILANT PHARMOVA LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.